Margo P. Cohen, M.D.

Services:

  • Scientific and medical evaluation of healthcare and life science investment opportunities
  • Evaluation of and guidance for FDA submission process including NDAs, Clinical Trials, Clinical Diagnostics and Devices
  • Assessment of product need, utility and efficacy

 

Clients:

  • Pharmaceutical companies, hedge funds, venture capital funds, money managers, innovators, inventors, start-ups
  • Innovators seeking to fund ideas with the goal of developing and bringing products to market.

Background

Dr. Cohen is an internationally recognized endocrinologist with a distinguished career in academic medicine and is known for her clinical expertise and groundbreaking research in complications of diabetes. Her extensive experiential base in academic medicine, industry and peer review of scientific/medical projects and publications provides a broad appreciation of unmet medical needs and of the investigative and clinical issues that must be addressed for successful development of new healthcare products.

She has served as:

  • Founder and President of Glycadia, a biomedical company developing therapeutic products for complications of diabetes, and its sister division Exocell that creates and markets diagnostic products for clinical and investigative laboratories in the diabetes arena
  • Professor of Medicine and Director of Endocrinology and Metabolism at the WSU School of Medicine in Detroit and at the UMDNJ in New Jersey
  • Adjunct Professor of Biochemistry & Biophysics at the University of Pennsylvania
  • Visiting Professor at numerous universities in the United States and abroad
  • Career Investigator of the Argentine National Research Council at the University of Buenos Aires, performing thesis research for a Doctoral in Biochemistry.
  • Editor-in-chief of the journal Endocrinology and on the editorial board of Diabetes and other professional journals
  • On Advisory Committees and scientific study panels of the National Institutes of Health, the American Diabetes Association, and the Juvenile Diabetes Foundation
  • Chair of the Board of Scientific Counselors of a Member Institute of the NIH (twice appointed)
  • An invited peer-reviewer for various important scientific journals.

Her responsibilities in these capacities have included:

  • Review and evaluation of scientific and technological programs, and the timely achievement of program goals
  • Spearheading investigative programs, discovery, preclinical and clinical development of new drug products and medical devices
  • Preparation of New Drug Applications and applications for new devices that have been approved by the FDA.
  • Design and oversight of Phase 1-3 clinical trials

Other notable background includes:

  • Long-standing research interests in the pathogenesis of vascular complications of diabetes that have been supported for many years by the National Institutes of Health
  • Recognition with several awards
  • Fulbright Scholarship

Publications

Dr. Cohen has authored over 130 original publications in the scientific and professional literature

Google Scholar

and several books, book chapters and monographs in the areas of diabetes, endocrinology and biochemistry

Margo Cohen on Wikipedia

Get in Touch

Margo P. Cohen, M.D.

Services:

  • Scientific and medical evaluation of healthcare and life science investment opportunities
  • Evaluation of and guidance for FDA submission process including NDAs, Clinical Trials, Clinical Diagnostics and Devices
  • Assessment of product need, utility and efficacy

 

Clients:

  • Pharmaceutical companies, hedge funds, venture capital funds, money managers, innovators, inventors, start-ups
  • Innovators seeking to fund ideas with the goal of developing and bringing products to market.

Background

Dr. Cohen is an internationally recognized endocrinologist with a distinguished career in academic medicine and is known for her clinical expertise and groundbreaking research in complications of diabetes. Her extensive experiential base in academic medicine, industry and peer review of scientific/medical projects and publications provides a broad appreciation of unmet medical needs and of the investigative and clinical issues that must be addressed for successful development of new healthcare products.

She has served as:

  • Founder and President of Glycadia, a biomedical company developing therapeutic products for complications of diabetes, and its sister division Exocell that creates and markets diagnostic products for clinical and investigative laboratories in the diabetes arena
  • Professor of Medicine and Director of Endocrinology and Metabolism at the WSU School of Medicine in Detroit and at the UMDNJ in New Jersey
  • Adjunct Professor of Biochemistry & Biophysics at the University of Pennsylvania
  • Visiting Professor at numerous universities in the United States and abroad
  • Career Investigator of the Argentine National Research Council at the University of Buenos Aires, performing thesis research for a Doctoral in Biochemistry.
  • Editor-in-chief of the journal Endocrinology and on the editorial board of Diabetes and other professional journals
  • On Advisory Committees and scientific study panels of the National Institutes of Health, the American Diabetes Association, and the Juvenile Diabetes Foundation
  • Chair of the Board of Scientific Counselors of a Member Institute of the NIH (twice appointed)
  • An invited peer-reviewer for various important scientific journals.

Her responsibilities in these capacities have included:

  • Review and evaluation of scientific and technological programs, and the timely achievement of program goals
  • Spearheading investigative programs, discovery, preclinical and clinical development of new drug products and medical devices
  • Preparation of New Drug Applications and applications for new devices that have been approved by the FDA.
  • Design and oversight of Phase 1-3 clinical trials

Other notable background includes:

  • Long-standing research interests in the pathogenesis of vascular complications of diabetes that have been supported for many years by the National Institutes of Health
  • Recognition with several awards
  • Fulbright Scholarship

Publications

Dr. Cohen has authored over 130 original publications in the scientific and professional literature

Google Scholar

and several books, book chapters and monographs in the areas of diabetes, endocrinology and biochemistry

Margo Cohen on Wikipedia

Get in Touch